A Prospective Observational Study of the Efficacy and Safety of CPT-11 Based Regimens for UGT1A1 Genotype Guided Patients With Metastatic Colorectal Cancer.
Phase of Trial: Phase IV
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid; Gimeracil/oteracil/tegafur
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 11 Oct 2016 Results evaluating a monogram for predicting overall survival presented at the 41st European Society for Medical Oncology Congress.
- 13 Jul 2016 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 Results of impact of UGT1A1 genotype on overall survival presented at the 52nd Annual Meeting of the American Society of Clinical Oncology